SARS-CoV-2 antibodies recognize 23 distinct epitopic sites on the receptor binding domain

Mostrar otras versiones (1)

The COVID-19 pandemic and SARS-CoV-2 variants have dramatically illustrated the need for a better understanding of antigen (epitope)-antibody (paratope) interactions. To gain insight into the immunogenic characteristics of epitopic sites (ES), we systematically investigated the structures of 340 Abs...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiang, Jiansheng, Boughter, Christopher T., Ahmad, Javeed, Natarajan, Kannan, Boyd, Lisa F., Meier-Schellersheim, Martin, Margulies, David H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Journal Experts 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275037/
https://www.ncbi.nlm.nih.gov/pubmed/37333174
http://dx.doi.org/10.21203/rs.3.rs-2800118/v1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10275037/
https://www.ncbi.nlm.nih.gov/pubmed/37333174
http://dx.doi.org/10.21203/rs.3.rs-2800118/v1

Ejemplares similares